June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.
June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.
May 30, 2019: Myocardial infarction risk among people with HIV; dolutegravir vs. efavirenz; a new way to estimate date of seroconversion; identifying people at imminent risk for disengagement from care.
The effect of vitamin D levels on CD4 count during HIV treatment; helping black men who have sex with men utilize PrEP; HIV and aortic stiffness; Legionnaires’ disease severity among people with HIV.
Clinical trials have a long history of few, if any, women being recruited or enrolled. But an important U.S. study on HIV and heart disease is addressing the barriers that keep women out of research studies.
Hepatitis C (HCV) and HIV infection were independently associated with markers of subclinical atherosclerosis -- including plaque and coronary artery calcium -- in a study of 994 men who have sex with men.
Obesity may lead to more cases of diabetes and hypertension in black women living with HIV when compared to white men living with HIV, according to an Alabama study.
HIV-positive African Americans with low vitamin D had more than a doubled risk of coronary artery disease in a study of 674 men and women in Baltimore, Maryland.1 Other traditional risk factors also raised the odds of coronary artery disease in these...
Even Among Long-Term HIV Nonprogressors, Some Signs of Heightened Cardiovascular Risk Exist, U.S. Study Finds
Cardiovascular risk may be slightly higher even among HIV-positive people whose immune systems are able to keep HIV at bay without the help of antiretrovirals, according to a small study by U.S. researchers presented at ICAAC 2010. The findings are f...
Gender and Race Subgroup Analyses in a Prospective Study of Hyperlipidemia in ART-Naive Subjects Taking Trizivir (TZV), Combivir (COM)/Nelfinavir (NFV), or Stavudine (d4T)/Lamivudine (3TC)/NFV (Oral 57) Authored by K. Tashima, P. Kumar, A. Rodr...